Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients
- 1 March 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 40 (2) , 191-194
Abstract
Background Aripiprazole (ARI), an antipsychotic drug used to treat various mental health disorders, has recently been associated with the emergence of problem gambling (PBG). However, few cases have been reported in the schizophrenia-related psychotic disorders population, and even fewer provided sufficient details to systematically assess the causality of the association. Methods This article describes 6 cases with first-episode psychosis in whom PBG emerged while on ARI. Detailed information was gathered from clinical staff and patients' families to systematically assess the causal link between ARI and the emergence of PBG using the Naranjo and Liverpool Adverse Drug Reaction scales. Findings Five of these cases were previously diagnosed with a substance use disorder and/or cluster B personality traits. Five had received a more potent dopaminergic antagonist treatment before being switched to ARI. Two of them had presented PBG before being diagnosed with a psychotic disorder. The level of certainty about the causal role of ARI varied from possible to certain, and in 4 cases, the 2 scales yielded different ratings. Implications Although these cases suggest that ARI may be associated with the emergence of PBG in the early course of schizophrenia-related psychotic disorders, they cannot prove the causality or the strength of this association. They provide the impetus to perform adequately powered and well-controlled prospective studies to draw more definite conclusion about the causality of this association and, in the meantime, further emphasize the need to carefully assess PBG in this population.Keywords
This publication has 15 references indexed in Scilit:
- Case Reports of Aripiprazole and Problematic Gambling in SchizophreniaJournal of Clinical Psychopharmacology, 2019
- Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptorsSynapse, 2015
- Reports of Pathological Gambling, Hypersexuality, and Compulsive Shopping Associated With Dopamine Receptor Agonist DrugsJAMA Internal Medicine, 2014
- Aripiprazole: A new risk factor for pathological gambling? A report of 8 case reportsAddictive Behaviors, 2014
- Pharmacotherapy challenges in patients with first-episode psychosisJournal of Affective Disorders, 2012
- Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment ToolPLOS ONE, 2011
- Pathological behaviors provoked by dopamine agonist therapy of Parkinson's diseasePhysiology & Behavior, 2011
- A Cross-Sectional Study of Problem and Pathological Gambling in Patients With Schizophrenia/Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2009
- Methods for Causality Assessment of Adverse Drug ReactionsDrug Safety, 2008
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981